Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,183,421
+$1,183,409 QoQ
Shares Held
84,892
+63.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Derivatives in DNLI
reported options exposure · as of Dec 31, 2023CallValue
$482,850
CallShares
22,500
PutValue
$482,850
PutShares
22,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,160 across 455 Biotechnology names. DNLI ranks #73 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in DNLI
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,183,421 | 84,892 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,000,012 | 52,084 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,725,496 | 407,359 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,345,254 | 437,001 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $5,959,474 | 425,981 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $3,271,609 | 240,648 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $5,667,005 | 278,067 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $7,453,871 | 255,883 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $2,950,333 | 127,060 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $3,110,011 | 151,560 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $482,850 | 22,500 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $482,850 | 22,500 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $6,953,447 | 324,019 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $3,435,039 | 166,507 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $4,676,212 | 158,462 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $15,124,078 | 656,427 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $16,295,686 | 585,965 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $9,988,581 | 325,467 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $10,852,930 | 368,771 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,870,106 | 58,132 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,388,616 | 120,821 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $3,580,184 | 70,965 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,863,812 | 23,761 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,126,038 | 89,773 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,881,081 | 22,458 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,032,405 | 28,814 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $860,541 | 35,589 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $314,653 | 17,970 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||